Suchergebnisse - "Imada, Kazunori"

PubPharm (227)

1

A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia

enthalten in: International journal of hematology | 2024

von Usuki, K. | Miyamoto, T. | Yamauchi, T. | +49

2

Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab : a multicenter retrospective study

enthalten in: Annals of hematology | 2024

von Nakamura, N. | Arima, N. | Takakuwa, T. | +25

3

Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma : retrospective analysis of 598 cases from Kansai Myeloma Forum

enthalten in: International journal of hematology | 2023

von Shimura, Y. | Shibayama, H. | Nakaya, A. | +27

4

Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin

enthalten in: ResearchSquare.com | 2023

von Shimazu, Y. | Kanda, J. | Kosugi, S. | +29

5

Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan

enthalten in: Annals of hematology | 2023

von Iemura, T. | Kondo, T. | Ueda, A. | +22

6

Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment

enthalten in: American journal of hematology | 2023

von Naka, R. | Kondo, T. | Nishikubo, M. | +14

7

Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphoma

enthalten in: Bone marrow transplantation | 2023

von Inoue, Y. | Morishima, S. | Kato, K. | +16

8

Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum

enthalten in: International journal of hematology | 2023

von Shimura, Y. | Shibayama, H. | Nakaya, A. | +27

9

Anti-CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma : An update of the phase 1/2 ISLANDs study

enthalten in: Hematological oncology | 2023

von Sunami, K. | Fuchida, S. | Suzuki, K. | +17

10

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms

enthalten in: Blood advances | 2023

von Nannya, Y. | Tobiasson, M. | Sato, S. | +35

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]